Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 975 of 3173 entries
View as:

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

Phase: N/A Priority: Normal
NCT ID: NCT01128439 Org: User:
Start: 07/31/10 End: 04/30/15 Due: 04/30/16

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT01601821 Org: User:
Start: 04/30/06 End: 03/31/08 Due: 03/31/09

Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Phase: N/A Priority: Normal
NCT ID: NCT00977015 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845

Phase: N/A Priority: Normal
NCT ID: NCT00856258 Org: User:
Start: 03/31/09 End: 06/30/09 Due: 06/30/10

Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00691093 Org: User:
Start: 07/31/08 End: 06/30/09 Due: 06/30/10

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01033487 Org: User:
Start: 01/31/10 End: 06/30/10 Due: 06/30/11

Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03796182 Org: User:
Start: 01/10/19 End: 03/12/19 Due: 03/12/20

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05263921 Org: User:
Start: 03/10/22 End: 05/19/22 Due: 05/19/23

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Phase: N/A Priority: Normal
NCT ID: NCT04507776 Org: User:
Start: 09/01/20 End: 10/01/20 Due: 10/01/21

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Phase: N/A Priority: Normal
NCT ID: NCT02501902 Org: User:
Start: 11/23/15 End: 12/27/18 Due: 12/27/19

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02528253 Org: User:
Start: 08/18/15 End: 12/20/18 Due: 12/20/19

Parecoxib In Post Surgery (Hemicolectomy) Pain

Phase: N/A Priority: Normal
NCT ID: NCT00139607 Org: User:
Start: 09/30/02 End: 01/31/05 Due: 01/31/06

Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00511849 Org: User:
Start: 11/30/05 End: 02/28/09 Due: 02/28/10

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Phase: N/A Priority: Normal
NCT ID: NCT01595438 Org: User:
Start: 10/31/12 End: 08/31/14 Due: 08/31/15

CP-481,715 Nickel Allergy Study.

Phase: N/A Priority: Normal
NCT ID: NCT00141180 Org: User:
Start: 09/30/03 End: 10/31/05 Due: 10/31/06

Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46

Phase: N/A Priority: Normal
NCT ID: NCT04410809 Org: User:
Start: 01/19/18 End: 11/27/19 Due: 11/27/20

Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02929576 Org: User:
Start: 09/30/16 End: - Due: -

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants

Phase: N/A Priority: Normal
NCT ID: NCT00143312 Org: User:
Start: 02/28/05 End: 04/30/08 Due: 04/30/09

A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01500824 Org: User:
Start: 05/31/14 End: 05/31/16 Due: 05/31/17

A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00550446 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00384033 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT00601484 Org: User:
Start: 03/17/08 End: 04/15/09 Due: 04/15/10

12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.

Phase: N/A Priority: Normal
NCT ID: NCT00150254 Org: User:
Start: 09/30/01 End: 10/31/02 Due: 10/31/03

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Phase: N/A Priority: Normal
NCT ID: NCT07029828 Org: User:
Start: 07/14/25 End: 05/31/30 Due: 05/31/31

Brain Imaging To Examine The Effect Of Naproxen In Hand Osteoarthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00830050 Org: User:
Start: 07/31/10 End: 12/31/10 Due: 12/31/11